Literature DB >> 18122024

Treatment of alcoholism with a sensitizing drug.

O MARTENSEN-LARSEN.   

Abstract

Entities:  

Keywords:  ALCOHOLISM/therapy

Mesh:

Year:  1948        PMID: 18122024     DOI: 10.1016/s0140-6736(48)91515-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Disposition kinetics in dogs of diethyldithiocarbamate, a metabolite of disulfiram.

Authors:  J Cobby; M Mayersohn; S Selliah
Journal:  J Pharmacokinet Biopharm       Date:  1978-10

2.  Disulfiram Implantation for the Treatment of Alcoholism: Clinical Experiences from the Plastic Surgeon's Point of View.

Authors:  Billur Sezgin; Serhat Sibar; Hakan Bulam; Kemal Findikcioglu; Serhan Tuncer; Bilge Dogan
Journal:  Arch Plast Surg       Date:  2014-09-15

3.  Post-soviet placebos: epistemology and authority in Russian treatments for alcoholism.

Authors:  Eugene Raikhel
Journal:  Cult Med Psychiatry       Date:  2010-03

4.  Disulfiram (Antabuse) Activates ROS-Dependent ER Stress and Apoptosis in Oral Cavity Squamous Cell Carcinoma.

Authors:  Priyanka Shah O'Brien; Yue Xi; Justin R Miller; Amy L Brownell; Qinghua Zeng; George H Yoo; Danielle M Garshott; Matthew B O'Brien; Anthony E Galinato; Peter Cai; Neha Narula; Michael U Callaghan; Randal J Kaufman; Andrew M Fribley
Journal:  J Clin Med       Date:  2019-05-06       Impact factor: 4.241

5.  Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trial.

Authors:  Kerstin K Antonsen; Mette K Klausen; Amanda S Brunchmann; Nina le Dous; Mathias E Jensen; Kamilla Woznica Miskowiak; Patrick M Fisher; Gerda K Thomsen; Henrik Rindom; Thomas P Fahmy; Sabine Vollstaedt-Klein; Helene Benveniste; Nora D Volkow; Ulrik Becker; Claus Ekstrøm; Gitte Moos Knudsen; Tina Vilsbøll; Anders Fink-Jensen
Journal:  BMJ Open       Date:  2018-07-16       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.